KevinMD.com: Social media’s leading physician voice
The KevinMD newsletter Real physician voices, twice a weekFree, and one click to unsubscribe.
Subscribe free →

More Fosamax and jaw osteonecrosis

Dr. RW comments on this worsening hysteria:

Concerning my reference to a linked study showing that the major incidence of ONJ is with parenteral biphosphonates in patients with myeloma or metastatic bone disease she states: “That simply isn’t true. Oral surgeons and dentists have been seeing patient after patient with jaw necrosis from Fosamax and other bisphosphonate drugs.”

Wait a minute. Not so simply, please. According to the systematic review the oncology patients on parenteral therapy represent 94% of published cases despite much heavier use of oral biphosphonates such as Fosamax.

Share this articleLinkedInFacebookXEmail

Real physician voices, twice a week

Free, and one click to unsubscribe.

No spam. We never share your email.